BioCryst Pharmaceuticals Inc
BCRX Real Time Price USDRecent trades of BCRX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by BCRX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$10,000 Oct 22, 2018 Issue: None
-
$20,000 Jul 20, 2018 Issue: None
-
$20,000 Jul 20, 2018 Issue: None
-
$20,000 Apr 20, 2018 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Apr 20, 2018 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Jan 22, 2018 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Jan 22, 2018 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Oct 20, 2017 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Oct 20, 2017 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Jul 20, 2017 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Jul 20, 2017 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Apr 20, 2017 Issue: Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs
-
$20,000 Apr 20, 2017 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Jan 23, 2017 Issue: Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs
-
$20,000 Jan 23, 2017 Issue: Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs
-
$20,000 Oct 20, 2016 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Oct 20, 2016 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Sep 26, 2016 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Jul 20, 2016 Issue: Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs
-
$20,000 Jul 20, 2016 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Apr 20, 2016 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$40,000 Jan 20, 2016 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Jan 20, 2016 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Oct 20, 2015 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$40,000 Oct 20, 2015 Issue: Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs
-
$40,000 Jul 20, 2015 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$20,000 Jul 20, 2015 Issue: Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs
-
$20,000 Apr 20, 2015 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$40,000 Apr 20, 2015 Issue: Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs
-
$40,000 Jan 20, 2015 Issue: Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs
-
$20,000 Jan 20, 2015 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$40,000 Oct 20, 2014 Issue: Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs
-
$20,000 Oct 20, 2014 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$40,000 Jul 21, 2014 Issue: Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs
-
$20,000 Jul 21, 2014 Issue: Medical/Disease Research/Clinical Labs Disaster Planning/Emergencies
-
$10,000 Apr 21, 2014 Issue: Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs
-
$10,000 Apr 21, 2014 Issue: Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs
-
$10,000 Apr 07, 2014 Issue: Medical/Disease Research/Clinical Labs Defense Health Issues Homeland Security
-
$40,000 Oct 21, 2013 Issue: Pharmacy Defense Disaster Planning/Emergencies Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Oct 21, 2013 Issue: Medical/Disease Research/Clinical Labs Pharmacy Health Issues Disaster Planning/Emergencies Defense
-
$40,000 Jul 22, 2013 Issue: Health Issues Disaster Planning/Emergencies Pharmacy Medical/Disease Research/Clinical Labs Defense
-
$20,000 Jul 22, 2013 Issue: Medical/Disease Research/Clinical Labs Pharmacy Health Issues Disaster Planning/Emergencies Defense
-
$30,000 Jul 18, 2013 Issue: Homeland Security Health Issues Budget/Appropriations Medical/Disease Research/Clinical Labs Science/Technology Defense
-
$30,000 Oct 20, 2011 Issue: Health Issues
-
$20,000 Oct 17, 2011 Issue: Medical/Disease Research/Clinical Labs
-
$50,000 Jul 20, 2011 Issue: Health Issues
-
$30,000 Jul 20, 2011 Issue: Medical/Disease Research/Clinical Labs
-
$50,000 Apr 20, 2011 Issue: Health Issues
-
$30,000 Apr 12, 2011 Issue: Medical/Disease Research/Clinical Labs
-
$50,000 Jan 20, 2011 Issue: Health Issues
-
$30,000 Jan 18, 2011 Issue: Medical/Disease Research/Clinical Labs
-
$40,000 Jan 18, 2011 Issue: Medical/Disease Research/Clinical Labs
-
$50,000 Oct 20, 2010 Issue: Health Issues
-
$50,000 Oct 14, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Oct 14, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$50,000 Jul 20, 2010 Issue: Health Issues
-
$30,000 Jul 19, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Jul 12, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$50,000 Apr 20, 2010 Issue: Health Issues
-
$50,000 Apr 19, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Apr 12, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Jan 20, 2010 Issue: Health Issues
-
$30,000 Jan 14, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Jan 13, 2010 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Oct 13, 2009 Issue: Health Issues
-
$30,000 Oct 13, 2009 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Jul 10, 2009 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Apr 16, 2009 Issue: Medical/Disease Research/Clinical Labs
-
$30,000 Jan 13, 2009 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Oct 17, 2008 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jul 16, 2008 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Apr 17, 2008 Issue: Medical/Disease Research/Clinical Labs
-
$40,000 Feb 05, 2008 Issue: Medical/Disease Research/Clinical Labs
-
$40,000 Aug 13, 2007 Issue: Homeland Security Economics/Economic Development
-
$40,000 Feb 13, 2007 Issue: Homeland Security
-
$40,000 Jul 27, 2006 Issue: Medical/Disease Research/Clinical Labs Homeland Security
-
$40,000 Feb 14, 2006 Issue: Medical/Disease Research/Clinical Labs Homeland Security
-
$40,000 Jul 29, 2005 Issue: Homeland Security Medical/Disease Research/Clinical Labs
Estimated quarterly lobbying spending
BCRX Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
- $382,301 2025-06-18 00:00:00 Agency: Department of Veterans Affairs
- $385,448 2024-11-04 00:00:00 Agency: Department of Veterans Affairs
- $345,808 2024-10-01 00:00:00 Agency: Department of Veterans Affairs
- $13,877,674 2024-09-23 00:00:00 Agency: Department of Health and Human Services
- $374,626 2024-09-09 00:00:00 Agency: Department of Veterans Affairs
- $385,448 2024-03-12 00:00:00 Agency: Department of Veterans Affairs
- $201,722 2024-03-01 00:00:00 Agency: Department of Veterans Affairs
- $88,950 2024-02-20 00:00:00 Agency: Department of Veterans Affairs
- $29,650 2024-02-16 00:00:00 Agency: Department of Veterans Affairs
- $340,322 2023-01-20 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $368,683 2022-05-20 00:00:00 Agency: None
- $85,081 2022-03-08 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $0 2021-05-18 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $0 2021-05-05 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $0 2021-03-08 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded from public contracts
Recent insights relating to BCRX
Recent picks made for BCRX stock on CNBC
ETFs with the largest estimated holdings in BCRX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $BCRX stock a Buy, Sell, or Hold?
- What is the price target for $BCRX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $BCRX stock?
- Who owns the most shares of $BCRX stock?
- What funds own $BCRX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BCRX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.